Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Viemed Healthcare (VMD) Shares Outstanding (Diluted Average) (2018 - 2026)

Viemed Healthcare filings provide 8 years of Shares Outstanding (Diluted Average) readings, the most recent being $40.8 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding (Diluted Average) changed 0.05% to $40.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $40.8 million, a 0.05% change, with the full-year FY2025 number at $40.8 million, changed 0.05% from a year prior.
  • Shares Outstanding (Diluted Average) hit $40.8 million in Q4 2025 for Viemed Healthcare, down from $41.1 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $41.6 million in Q1 2025 to a low of $39.8 million in Q2 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $40.6 million (2021), compared with a mean of $40.6 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): fell 2.68% in 2022 and later grew 2.68% in 2025.
  • Viemed Healthcare's Shares Outstanding (Diluted Average) stood at $40.7 million in 2021, then decreased by 2.15% to $39.8 million in 2022, then rose by 1.44% to $40.4 million in 2023, then grew by 1.06% to $40.8 million in 2024, then grew by 0.05% to $40.8 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $40.8 million (Q4 2025), $41.1 million (Q3 2025), and $41.4 million (Q2 2025) per Business Quant data.